Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

NCT00178607 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT00178607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00178607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Observational
Overall status
Completed
Start date
August 31, 2002
Completion date
October 31, 2015
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a